Wyvern Pharmaceuticals Inc. Company Profile, Contacts & Intelligence

Wyvern Pharmaceuticals Inc. Overview

Founded in 2017, Wyvern Pharmaceuticals Inc. is a privately held biopharmaceutical company headquartered in Calgary, Canada. Our executive team brings together decades of experience in drug development and taking new therapies to market. Together, we aim to deliver meaningful quality of life and lifespan extension benefits to patient populations with serious unmet treatment needs. Our proprietary technologies use gene therapy to safely and effectively treat serious illnesses, including autoimmune disorders, cancer and infectious diseases. Our lead agent is WYV-RA, a gene therapy that treats rheumatoid arthritis by upregulating CTLA4 in target tissues, and downregulating TNF so that it is not excreted by the target tissues. Planning for a randomized clinical study in RA patients is now underway. Our follow-on agent is WYV-ONC, a gene therapy that treats cancer by upregulating TLR3 in target tumours and overcomes immunotherapy treatment resistance when used in combination with immunotherapies such as checkpoint inhibitors.

Headquarters

Calgary, Alberta, Ca

Website

wyvernpharma.com

Industry

Biotechnology Research

Founded

2017

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Wyvern Pharmaceuticals Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Wyvern Pharmaceuticals Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Wyvern Pharmaceuticals Inc. Workforce Composition

Seniority breakdown across 3 visible profiles.

Compare Similar Companies to Wyvern Pharmaceuticals Inc.

Explore companies in related markets and compare their industry and employee estimates.